| Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry DL Horn, D Neofytos, EJ Anaissie, JA Fishman, WJ Steinbach, AJ Olyaei, ... Clinical infectious diseases 48 (12), 1695-1703, 2009 | 1235 | 2009 |
| Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH … D Neofytos, D Horn, E Anaissie, W Steinbach, A Olyaei, J Fishman, ... Clinical Infectious Diseases 48 (3), 265-273, 2009 | 944 | 2009 |
| Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled … JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ... The Lancet 387 (10020), 760-769, 2016 | 914 | 2016 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 768 | 2021 |
| Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients D Neofytos, JA Fishman, D Horn, E Anaissie, CH Chang, A Olyaei, ... Transplant Infectious Disease 12 (3), 220-229, 2010 | 520 | 2010 |
| Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008 M Pfaller, D Neofytos, D Diekema, N Azie, HU Meier-Kriesche, SP Quan, ... Diagnostic microbiology and infectious disease 74 (4), 323-331, 2012 | 486 | 2012 |
| The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012 N Azie, D Neofytos, M Pfaller, HU Meier-Kriesche, SP Quan, D Horn Diagnostic microbiology and infectious disease 73 (4), 293-300, 2012 | 299 | 2012 |
| Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients CD Alonso, SB Treadway, DB Hanna, CA Huff, D Neofytos, KC Carroll, ... Clinical infectious diseases 54 (8), 1053-1063, 2012 | 235 | 2012 |
| Treatment of adenovirus disease in stem cell transplant recipients with cidofovir D Neofytos, A Ojha, B Mookerjee, J Wagner, J Filicko, A Ferber, ... Biology of Blood and Marrow Transplantation 13 (1), 74-81, 2007 | 215 | 2007 |
| Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study C Van Delden, S Stampf, HH Hirsch, O Manuel, P Meylan, A Cusini, ... Clinical infectious diseases 71 (7), e159-e169, 2020 | 188 | 2020 |
| Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, -Three Volume Set ML Grayson, S Cosgrove, S Crowe, W Hope, J McCarthy, J Mills, ... CRC Press, 2017 | 157 | 2017 |
| Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection RK Avery, R Arav-Boger, KA Marr, E Kraus, S Shoham, L Lees, ... Transplantation 100 (10), e74-e80, 2016 | 153 | 2016 |
| Risk factors for candidemia: a prospective matched case-control study J Poissy, L Damonti, A Bignon, N Khanna, M Von Kietzell, K Boggian, ... Critical care 24, 1-11, 2020 | 149 | 2020 |
| Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experience D Neofytos, S Treadway, D Ostrander, CD Alonso, KL Dierberg, ... Transplant Infectious Disease 15 (3), 233-242, 2013 | 146 | 2013 |
| First experience of SARS‐CoV‐2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study J Tschopp, AG L'Huillier, M Mombelli, NJ Mueller, N Khanna, C Garzoni, ... American Journal of Transplantation 20 (10), 2876-2882, 2020 | 126 | 2020 |
| Donor‐Derived Trypanosoma cruzi Infection in Solid Organ Recipients in the United States, 2001–2011 S Huprikar, E Bosserman, G Patel, A Moore, S Pinney, A Anyanwu, ... American Journal of Transplantation 13 (9), 2418-2425, 2013 | 123 | 2013 |
| Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy D Neofytos, K Lu, A Hatfield-Seung, A Blackford, KA Marr, S Treadway, ... Diagnostic microbiology and infectious disease 75 (2), 144-149, 2013 | 119 | 2013 |
| A first update on mapping the human genetic architecture of COVID-19 Writing group lead Andrews Shea J. 6 Kanai Masahiro 3 Cordioli Mattia 7, ... Nature 608 (7921), E1-E10, 2022 | 110 | 2022 |
| Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections DL Horn, JA Fishman, WJ Steinbach, EJ Anaissie, KA Marr, AJ Olyaei, ... Diagnostic microbiology and infectious disease 59 (4), 407-414, 2007 | 102 | 2007 |
| Epidemiology of Candida kefyr in patients with hematologic malignancies SF Dufresne, KA Marr, E Sydnor, JF Staab, JE Karp, K Lu, SX Zhang, ... Journal of clinical microbiology 52 (6), 1830-1837, 2014 | 90 | 2014 |
Nina KhannaProfessor of Infectious Diseases, University and University Hospital of Basel在 usb.ch 的电子邮件经过验证
